Skip to content
healthcare.dev
Get a free key

WEGOVY

NDC 0169-4425, semaglutide, tablet, from Novo Nordisk Pharmaceutical Industries, LP.

Product NDC
0169-4425
Status
Listed
Labeler
Novo Nordisk Pharmaceutical Industries, LP
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218316
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0169-4425 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SEMAGLUTIDE25 mg/1

Pharmacologic classes

GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Package NDCNDC-11Package
0169-4425-310016944253130 TABLET in 1 BOTTLE, PLASTIC (0169-4425-31)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ee06186f-2aa3-4990-a760-757579d8f77b

  • NADAC price for package 00169442531

    GET /v1/drugs/nadac/00169442531

Use it

Look up 0169-4425 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0169-4425 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0169-4425. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.